Jun 17, 2020 / 12:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by and welcome to Geron's Key Opinion Leader Conference Call. (Operator Instructions) I would now like to hand the conference over to your moderator for today, Suzanne Messere, Head of Investor Relations. Ms. Messere, please go ahead.
Suzanne Messere - Geron Corporation - Head of IR & Corporate Communications
Thanks, Jack. Welcome to Geron's KOL event to discuss recent data presented at the virtual edition of the 25th Annual European Hematology Annual Congress.
I am joined today by Geron's Chief Medical Officer, Dr. Aleksandra Rizo; Dr. Valeria Santini; Dr. John Mascarenhas; Dr. Rami Komrokji; and Geron's Chairman and CEO, Dr. John Scarlett. Before we begin, please note that this presentation and question-and-answer session will contain forward-looking statements relating to Geron's plans, expectations, time lines, beliefs, statements of potentiality and projections. These include, without limitation, those regarding that imetelstat has potential disease-modifying activity and that Geron has a plan to
Geron Corporation - Special Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
